Cargando…
Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing
OBJECTIVES: To evaluate image quality by first use of LumiVision® in dynamic MR swallowing, a contrast medium consisting of biological substances versus a gadolinium-buttermilk mixture in patients who underwent Nissen fundoplication due to gastroesophageal reflux disease (GERD). METHODS: The protoco...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523424/ https://www.ncbi.nlm.nih.gov/pubmed/33893856 http://dx.doi.org/10.1007/s00330-021-07927-5 |
_version_ | 1784585297773723648 |
---|---|
author | Kulinna-Cosentini, Christiane Arnoldner, Michael A. Schima, Wolfgang Kristo, Ivan Schoppmann, Sebastian F. Weber, Michael Cosentini, Enrico P. |
author_facet | Kulinna-Cosentini, Christiane Arnoldner, Michael A. Schima, Wolfgang Kristo, Ivan Schoppmann, Sebastian F. Weber, Michael Cosentini, Enrico P. |
author_sort | Kulinna-Cosentini, Christiane |
collection | PubMed |
description | OBJECTIVES: To evaluate image quality by first use of LumiVision® in dynamic MR swallowing, a contrast medium consisting of biological substances versus a gadolinium-buttermilk mixture in patients who underwent Nissen fundoplication due to gastroesophageal reflux disease (GERD). METHODS: The protocol of this retrospective study was approved by the local Institutional Review Board. A hundred twenty-nine patients (146 examinations) underwent a dynamic MR swallowing study (at 1.5 T or 3.0 T) and received an oral contrast agent. Two readers evaluated the distention of the esophagus, contrast, and traceability of the bolus in a 3-point scale. A steady-state coherent sequence (B-FFE, TrueFISP) was used. The patients were divided into 3 different groups: 53 patients received gadolinium chelate (Dotarem®)–buttermilk mixture (GBM) in a dilution of 1:40 as an oral contrast agent; 44 patients received LumiVision® water mixture (LWM) in a dilution of 1:1 and 49 patients received LumiVision® (L) undiluted. RESULTS: GBM showed significantly better results in overall evaluation for both readers in contrast to LWM (p = .003, p = .002). L also reached significantly better results in overall evaluation than LWM in both readers (p = .004, p = .042). There was no significant difference in the overall evaluation between L and GBM (p = .914, p = .376).According to Landis and Koch, interobserver agreement was “substantial” (Cohen’s kappa = 0.738) between both readers. CONCLUSION: LumiVision® undiluted showed equal image quality compared to gadolinium-buttermilk mixture. The constellation of LumiVision® water mixture led to a clearly negative result in relation to the image quality compared to LumiVision® undiluted. Therefore, oral ingestion of LumiVision® undiluted is recommended for MR swallowing examinations. KEY POINTS: • LumiVision® undiluted shows significantly better image quality in comparison to LumiVision® diluted in oral application in swallowing MRI. • LumiVision® undiluted shows equal image quality in comparison to gadolinium-buttermilk mixture in oral application. • Oral ingestion of LumiVision® undiluted can replace gadolinium-buttermilk mixture in oral MR examinations. |
format | Online Article Text |
id | pubmed-8523424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85234242021-10-22 Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing Kulinna-Cosentini, Christiane Arnoldner, Michael A. Schima, Wolfgang Kristo, Ivan Schoppmann, Sebastian F. Weber, Michael Cosentini, Enrico P. Eur Radiol Gastrointestinal OBJECTIVES: To evaluate image quality by first use of LumiVision® in dynamic MR swallowing, a contrast medium consisting of biological substances versus a gadolinium-buttermilk mixture in patients who underwent Nissen fundoplication due to gastroesophageal reflux disease (GERD). METHODS: The protocol of this retrospective study was approved by the local Institutional Review Board. A hundred twenty-nine patients (146 examinations) underwent a dynamic MR swallowing study (at 1.5 T or 3.0 T) and received an oral contrast agent. Two readers evaluated the distention of the esophagus, contrast, and traceability of the bolus in a 3-point scale. A steady-state coherent sequence (B-FFE, TrueFISP) was used. The patients were divided into 3 different groups: 53 patients received gadolinium chelate (Dotarem®)–buttermilk mixture (GBM) in a dilution of 1:40 as an oral contrast agent; 44 patients received LumiVision® water mixture (LWM) in a dilution of 1:1 and 49 patients received LumiVision® (L) undiluted. RESULTS: GBM showed significantly better results in overall evaluation for both readers in contrast to LWM (p = .003, p = .002). L also reached significantly better results in overall evaluation than LWM in both readers (p = .004, p = .042). There was no significant difference in the overall evaluation between L and GBM (p = .914, p = .376).According to Landis and Koch, interobserver agreement was “substantial” (Cohen’s kappa = 0.738) between both readers. CONCLUSION: LumiVision® undiluted showed equal image quality compared to gadolinium-buttermilk mixture. The constellation of LumiVision® water mixture led to a clearly negative result in relation to the image quality compared to LumiVision® undiluted. Therefore, oral ingestion of LumiVision® undiluted is recommended for MR swallowing examinations. KEY POINTS: • LumiVision® undiluted shows significantly better image quality in comparison to LumiVision® diluted in oral application in swallowing MRI. • LumiVision® undiluted shows equal image quality in comparison to gadolinium-buttermilk mixture in oral application. • Oral ingestion of LumiVision® undiluted can replace gadolinium-buttermilk mixture in oral MR examinations. Springer Berlin Heidelberg 2021-04-24 2021 /pmc/articles/PMC8523424/ /pubmed/33893856 http://dx.doi.org/10.1007/s00330-021-07927-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Gastrointestinal Kulinna-Cosentini, Christiane Arnoldner, Michael A. Schima, Wolfgang Kristo, Ivan Schoppmann, Sebastian F. Weber, Michael Cosentini, Enrico P. Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title | Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title_full | Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title_fullStr | Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title_full_unstemmed | Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title_short | Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing |
title_sort | performance of a new natural oral contrast agent (lumivision®) in dynamic mr swallowing |
topic | Gastrointestinal |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523424/ https://www.ncbi.nlm.nih.gov/pubmed/33893856 http://dx.doi.org/10.1007/s00330-021-07927-5 |
work_keys_str_mv | AT kulinnacosentinichristiane performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT arnoldnermichaela performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT schimawolfgang performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT kristoivan performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT schoppmannsebastianf performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT webermichael performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing AT cosentinienricop performanceofanewnaturaloralcontrastagentlumivisionindynamicmrswallowing |